A Multicenter, Open-label, Extension Study of theSafety and Tolerability of Sitravatinib Alone or inCombination with Other Anticancer Therapies inPatients with Advanced or Metastatic SolidMalignancies

Project: Research project

Project Details

Description

A Multicenter, Open-label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies
StatusActive
Effective start/end date6/7/21 → 5/31/26

Funding

  • MIRATI THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint